Biotechnology's Chairman Board Sold: What Investors Know
Insider moves can shed light on a company’s trajectory, but they aren’t a crystal ball. This guide breaks down biotec...
Redeeming credit card points can be tricky. Discover what to avoid to ensure you make the most out of your rewards and benefits.
19,422 articlesInsider moves can shed light on a company’s trajectory, but they aren’t a crystal ball. This guide breaks down biotec...
Curious about a nuclear-tech stock with big growth potential? This guide breaks down the case for buying oklo stock t...
Bakkt faces a pivotal year as crypto markets evolve and cash flow models mature. This guide explains what bakkt (bkkt...
As Nvidia gears up for a pivotal fiscal 2027 Q1 print, investors are weighing AI demand, data center momentum, and ma...
A new Belden stake filed with the SEC shows an investment firm buying $89.5 million worth of shares. This article bre...
The IPO market is shifting in 2026, and smart investors are turning to robo-advisors to balance access and risk. Lear...
A dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
A notable fund sold a sizable stake in a leading pet-food company, triggering questions about motive, timing, and imp...
Grail's stock has slid as its Galleri MCED test faced a major trial setback. This piece breaks down what happened, wh...
Speed isn’t everything in crypto, but it matters. This guide dives into why Avalanche is named among the avalanche fa...
A personal-finance story about a costly legal battle forces a rethink on whether to accept a partner's financial supp...
Poet Technologies has seen its stock retreat after a fast run-up. This guide breaks down why poet technologies stock ...